Loading clinical trials...
Loading clinical trials...
MULTICENTER, RANDOMIZED, DOUBLE BLIND, CONTROLLED, CLINICAL STUDY TO DEMONSTRATE THE THERAPEUTIC CLINICAL EQUIVALENCE OF TWO MOMETASONE NASAL SPRAYS IN THE RELIEF OF THE SIGNS AND SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS.
Conditions
Interventions
Mometasone furoate
Locations
1
Argentina
Swiss Medical Group
Buenos Aires, Buenos Aires F.D., Argentina
Start Date
October 1, 2012
Primary Completion Date
January 1, 2013
Completion Date
March 1, 2013
Last Updated
October 5, 2012
NCT05494346
NCT06704698
NCT06104540
NCT05022420
NCT04194216
NCT06483204
Lead Sponsor
PH&T S.p.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions